Finoriq research workspace
ACHIEVE LIFE SCIENCES, INC. (ACHV) SEC Filings & Filing Highlights
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes. Review ACHV SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
- Company
- ACHIEVE LIFE SCIENCES, INC. (ACHV)
- Ticker
- ACHV
- Market Cap
- $639.6M
- Latest Price
- $6.23
- Industry
- Diagnostics
ACHIEVE LIFE SCIENCES, INC. (ACHV) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for ACHIEVE LIFE SCIENCES, INC. (ACHV).
| Event | Form | Date |
|---|---|---|
| The following is a brief description of each matter voted upon at the Annual Meeting and the ce...The following is a brief description of each matter voted upon at the Annual Meeting and the certified voting results | 8-K5.07 | 2026-07-06 |
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K5.03 | 2026-07-06 |
| Appointment of Board Members On May 29, 2026, the Board of Directors (the “Board”) of Achieve L...Appointment of Board Members On May 29, 2026, the Board of Directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”) appointed... | 8-K5.02 | 2026-06-02 |
| Appointment of Board Member In connection with the previously reported private placement (the “...Appointment of Board Member In connection with the previously reported private placement (the “Private Placement”) of the Company’s securit... | 8-K5.02 | 2026-05-12 |
| Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business UpdatesAchieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates | 8-K2.02 | 2026-05-12 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.